Issues related to biosimilars reimbursement, supply chain and Medicare/Medicaid payment reform.
2026 · 2nd Quarter (Apr 1 - June 30)
BRISTOL-MYERS SQUIBB COMPANY
Filed by MILLER STRATEGIES, LLC.
Open official filingSource-reported fields
Filing overview
- Type
- 2nd Quarter - Report
- Posted
- Jul 20, 2026
- Income
- Not reported
- Expenses
- Not reported
- Registrant
- MILLER STRATEGIES, LLC
- Filing UUID
- c6c96252-6d0b-4146-8b55-e7fafff3f08a
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Issues related to biosimilars reimbursement, supply chain and Medicare/Medicaid payment reform.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.